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ABSTRACT (100-200 WORDS):
It is well established that for aerobic growth E.coli requires either 
Menaquinone (MK), Ubiquinone (Q) or 2-octaprenyl-3-methyl-6- 
methoxy-1,4-benzoquinone (MMQ) as electron carrier to grow on 
glycerol minimal medium (GMM). Therefore, a double mutant strain 
blocked in both the MK and Q pathways shouldn’t grow on GMM. The 
following double mutant strains were tested for growth on GMM
(A ubiE Amen A, AubiH Amen A, AubiF Amen A, AubiB AmenA and 
AyigP AmenA). Surprisingly, it was found that the AubiB AmenA 
mutant grew after a long lag and AubiF AmenA mutant grew as 
expected due to the Q pathway intermediate MMQ serving as 
electron carrier. In GMM AubiB AmenA double mutant showed an 
increase in the rate of growth and growth yield. It is a known fact that 
all the Q pathway gene mutants including ubiB cannot grow on 
succinate minimal medium (SMM). The ubiB mutant has been 
previously shown to accumulate small amount of Q in stationary 
phase. To our surprise, the double mutant was also able to grow on 
succinate and lactate minimal media once adapted to grow in GMM. 
Quinone analysis of the AubiB AmenA mutant using HPLC revealed 
that it made significant amount of Q. Therefore, the reason behind the 
growth of double mutant strain is due to increase in the amount of Q.
Introduction
The isoprenoid quinone ubiquinone (coenzyme Q: Q) is widespread amongst living 
organisms. Aerobic gram-negative bacteria and eukaryotes contain Q as the sole quinone. The 
facultative anaerobic Gram-negative bacterium E.coli contains Q, Menaquinone (MK) and 
Demethylmenaquinone (DMK). The quinonoid nucleus of Q and MK are derived from shikimate 
pathway via chorismate (Figure 1). The prenyl side chain of both Q and MK is derived from 
prenyl diphosphate. It is well established in bacteria and eukaryotes that Q is a component of the 
respiratory chain and plays a critical role in respiration and oxidative phosphorylation 
(Meganathan, 2001). It functions as an electron carrier serving as a link between the 
dehydrogenases and electron transport chain of E.coli, when oxygen and nitrate are used as 
electron acceptors under aerobic and anaerobic conditions respectively (Meganathan, 2001). In 
eukaryotes, in addition to the respiratory chain, Q is present in all cellular membranes in a 
reduced form, and in human and animal tissues it serves as an important antioxidant (Emester 
and Forsmark-Andree, 1993). The reduced form of Q-10, QH2-IO, is an efficient scavenger of 
free radicals and effectively prevents peroxidative damage to lipids (Frei, Kim, and Ames, 1990).
It is known that for aerobic growth E.coli requires either (MK), (Q) or 2-octaprenyl-3- 
methyl-6-methoxy-l,4-benzoquinone (MMQ) as electron carrier to grow on glycerol minimal 
medium (Gly.M.M) (Meganathan, 2010). The pathway for Q biosynthesis, the intermediates and 
the genes associated are shown in figure 1. It was previously shown that MMQ, an intermediate, 
accumulated by the ubiF mutant enables it to grow on Gly.M.M. In the current study, we are 
trying to identify whether any other Q biosynthetic intermediates can substitute for Q in the 
respiratory chain.
W  A series of double mutants were constructed as a part of this study. The MK pathway has
been blocked in all the double mutants analyzed by deleting the menA gene. Different Q pathway 
gene mutantions were introduced into the menA mutant strain individually to obtain the 
following double mutants. These double mutants do not make either Q or MK and they can grow 
on glycerol only if the Q pathway intermediate channels electrons to oxygen.





















































Figure 1: Ubiquinone and Menaquinone Biosynthetic pathways in E.coli. The 
steps catalyzed by yigP and ubiB genes are currently unknown. The yigP and 
ubiB gene mutant strains accumulate octaprenylphenol and hence regulate the 
Q biosynthesis pathway.
Methods
Construction of ubiB and yigP deletion mutants
The yigP and ubiB gene mutants were previously constructed in Meganathan’s lab. The 
single gene deletion mutant strains of ubiH, ubiF, menA and ubiE were obtained from Coli 
Genetic Stock Center (CGSC). All these mutant strains have Kanamycin cassette flanked by FRT 
sites (FLP recognition targets) instead of the actual gene (Datsenko and Wanner, 2000). 
Expression of the FLP-recombinase removes the central part of the disruption cassette, leaving 
behind a 81 bp “scar” sequence which is in the correct reading frame without stop codons. This 
allows the generation of non-polar, unmarked in-frame deletions and repeated use of the same 
resistance marker for making multiple knock-outs in the same strain (Baba et al, 2006). The 
plasmid pCP20 containing the FLP recombinase was transformed into the menA mutant strain to 
remove the cassette (Fig. 3). FLP synthesis and loss of the plasmid are induced at 42°C.
Construction of Double Mutants using PI transduction
Double mutant strains lacking Q and MK pathways are constructed as follows: Phage PI\
was grown individually on the donor mutant strains of ubiH, ubiF, ubiB, yigP, ubiE and ubiB 
having a kanamycin casette and the lysate was used to transduce the recipient mutant strain 
menA whose kanamycin cassette was previously deleted (Fig. 3). Transductants containing the 
desired double mutation in the chromosome were verified by screening using colonyPCR 
(Datsenko and Wanner, 2000).
Growth Curves of Various Mutants
The mutant strains were grown overnight in LB medium at 37°C with continuous 
shaking. The tubes containing the cultures were centrifuged and the supernatant was then 
discarded. The pellet was re-suspended in minimal salt solution and shaken at room temperature 
for 24 hours to deplete the nutrient pond. The starved cells were used as the inoculum for the 
growth curves in side arm flasks containing the medium. The carbon source used in side arm 
flasks for growth curves are succinate (SMM), lactate (LMM), glycerol (Gly.M.M), and glucose 
(GMM). The growth was monitored using a klett meter equipped with a red filter and readings 
were taken every 4 hours.
Estimating the growth yield
The cultures were grown in two one liter flasks each containing 250ml of Gly.M.M and 
were pelleted when the growth reached early stationary phase. The wet weight of the pellet was 
then determined to get the growth yield.
Results
The Double mutant AubiB AmenA can grow on Glycerol Minimal Media
Out of all the double mutant strains analyzed for growth on Gly.M.M and minimal media 
with casamino acids (CAA). The A ubiB AmenA and AubiF AmenA strains were able to grow 
(Figure 3). The growth of AubiF AmenA was expected because of MMQ. The A ubiB AmenA 
strain grew on Gly.M.M after 4 days. When the media was supplemented with casamino acids 
(CAA) the lag period was shortened by 2 days (Figure 4). When the AubiB AmenA strain adapted
to grown on Gly.M.M was re-inoculated in fresh Gly.M.M without CAA, the lag period was just 
one day. CAA contains 18 of the 20 established amino acids so we decided to analyze what 
specific amino acids aided in the growth of the double mutant. The amino acids contained in 
CAA are methionine, glutamine, tryptophan, glycine, arginine, lysine, serine, histidine, 
threonine, phenylalanine, isoleucine, tyrosine, alanine, cysteine, proline, leucine, aspartic acid, 
and valine. Comparison of growth in Gly.M.M with each amino acid was conducted in test
tubes. The amino acids that aided AubiB AmenA to grow were methionine, glutamine,
tryptophan, glycine, and arginine. All the double mutant strains were able to grow on GMM 
(Figure 5).
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Figure 4: Comparison of growth rates between wild type, AubiB Amen A: with CAA,
without CAA, and adapted.
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Figure 5: Growth of various double mutants aerobically on Gly.M.M.
The Double mutant AubiB Amen A can grow on Succinate and Lactate Minimal Media
Mutants blocked in Q pathway cannot grow on succinate, a characteristic feature seen 
among all Q pathway mutants. As seen in figure 6, once adapted to Gly.M.M the double mutant 
AubiB AmenA can grow on succinate and lactate, therefore; the double mutant is making enough 
Q to grow on succinate and lactate. The single mutant ubiB cannot grow on succinate even 
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Figure 6. Growth curve of adapted AubiB AmenA (new) double mutant in SMM and LMM.
The AubiB AmenA strain adapted to grow on glycerol and the wild type strains were 
grown in 1 liter flasks for quantification of wet cell weights. It was observed that for the identical 
volume of media of 470 m l, the wild type strain yielded 2.06 g whereas the A ubiB AmenA strain 
yielded 3.86 g.
Quinone Analysis using HPLC
The quinone content of AubiB, AubiB AmenA, AyigP and AyigP AmenA were analyzed 
using HPLC. The AyigP and AubiB mutants made little Q and lot of octaprenyl phenol (OP). 
When MK pathway was blocked by introducing menA mutation into ubiB deletion strain (AubiB 
AmenA), the amount of Q increased comparatively (Fig. 7 a,b). This increase in Q is probably 
responsible for the growth in Gly.M.M.
Growth Yield Comparison
Ai/b/'B:: Kan (Glycerol Minimal Media)
Figure 7 a: HPLC Analysis
AubiB MnenA (Glycerol Minimal Media)
Figure 7 b: HPLC Analysis
Conclusion
The double mutant A ubiB AmenA was able to grow in Gly.M.M and even succinate and 
lactate minimal medias once it was adapted to Gly.M.M. Quinone analysis revealed that A ubiB 
AmenA is able to make a small amount of Q even when Q and MK pathways are blocked. It is 
possible that the blocking of the MK pathway increases the pool of prenyl side chain inside the 
cell. The availability of excess prenyl diphosphate which is essential for Q formation may 
probably be contributing to the increased amount of Qin the AubiB AmenA double mutant strain 
compared to the individual AubiB strain. The increase in the amount of Q is probably 
contributing to its growth in Gly.M.M, SMM, and LMM. Further research must be done to 
identify the possible reason behind the increased growth yield in AubiB AmenA strain compared
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